Sonoma Pharmaceuticals, Inc. (SNOA) NASDAQ
1.16
-0.0261(-2.20%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.16
-0.0261(-2.20%)
Currency In USD
| Market Cap | 2.72M |
| Enterprise Value | -2.35M |
| P/E Ratio | -0.59 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0.11 |
| Price/Book Ratio | 0.58 |
| Enterprise/Revenue | 0.01 |
| Enterprise/EBITDA | -0.03 |
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.19 |
| Operating Margin | -0.16 |
| Return On Assets | -0.25 |
| Return On Equity | -0.86 |
| Revenue | 14.29M |
| Revenue/Share | 10.35 |
| Gross Profit | 5.47M |
| EBITDA | -3.57M |
| Net Income | -3.46M |
| Diluted EPS | -2.79 |
| Total Cash | 2.56M |
| Total Cash/Share | 1.5 |
| Total Debt | 655,000 |
| Total Debt/Equity | 0.19 |
| Current Ratio | 2.88 |
| Book Value Per Share | 2 |
| 52-Week Change | -66.01 |
| 52-Week High | 6.92 |
| 52-Week Low | 0.85 |
| Moving Average 50 Days | 1.67 |
| Moving Average 200 Days | 3.15 |
| Average Volume | 186,933 |
| Shares Outstanding | 1.73M |
| % Held by Institutions | 3.94 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | August 30, 2024 |